España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Cue Biopharma
CUE
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Cue Biopharma (CUE) Forecast
News
Earnings
Cue Biopharma (CUE) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Cue Biopharma (NASDAQ:CUE) Stock
Cue Biopharma Stock (NASDAQ: CUE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 15, 2024
Cue Biopharma shares are trading lower. The c...
Benzinga Newsdesk
Thursday, November 14, 2024
Cue Biopharma Q3 2024 GAAP EPS $(0.17) Beats ...
Benzinga Newsdesk
Friday, November 08, 2024
Cue Biopharma Shares Phase 1 Data At SITC 202...
Benzinga Newsdesk
Wednesday, October 30, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Friday, October 11, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, October 10, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Wednesday, October 09, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Monday, October 07, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Friday, October 04, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Thursday, October 03, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Monday, September 30, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Friday, September 27, 2024
Cue Biopharma shares are trading higher. The ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Cue Biopharma's $12M Public Offering Includes...
Benzinga Newsdesk
Thursday, September 26, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Cue BioPharma shares are trading lower after ...
Benzinga Newsdesk
Cue Biopharma Commenced Proposed Public Offer...
Benzinga Newsdesk
Tuesday, September 03, 2024
Cue Biopharma To Present At The Promise Of In...
Benzinga Newsdesk
Tuesday, August 20, 2024
Stifel Maintains Buy on Cue Biopharma, Lowers...
Benzinga Newsdesk
Monday, August 19, 2024
Cue Biopharma Q2 2024 GAAP EPS $(0.20) Beats ...
Benzinga Newsdesk
Thursday, August 15, 2024
Cue Biopharma, Inc. Reports Q2 Loss, Tops Revenue Estimates
Zacks
Friday, July 26, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Cue Bio...
Benzinga Newsdesk
Thursday, July 25, 2024
Cue Biopharma Announces Strategic Prioritizat...
Benzinga Newsdesk
Tuesday, June 04, 2024
Cue Biopharma Presents Updated Data From Phas...
Benzinga Newsdesk
Friday, May 10, 2024
Cue Biopharma shares are trading lower. The c...
Benzinga Newsdesk
Thursday, May 09, 2024
Cue Biopharma Q1 2024 Adj EPS $(0.25) Beats $...
Benzinga Newsdesk
Thursday, May 02, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Tuesday, April 09, 2024
Forecasting The Future: 4 Analyst Projections For Cue Biopharma
Benzinga Insights
Stifel Maintains Buy on Cue Biopharma, Mainta...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Cue Bioph...
Benzinga Newsdesk
Monday, April 08, 2024
Cue Biopharma Q1 EPS $(0.28) Misses $(0.27) E...
Benzinga Newsdesk
Wednesday, April 03, 2024
Piper Sandler Reiterates Overweight on Cue Bi...
Benzinga Newsdesk
Wednesday, March 13, 2024
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Cue Biopharma shares are trading higher after...
Benzinga Newsdesk
Jefferies Initiates Coverage On Cue Biopharma...
Benzinga Newsdesk
Monday, January 01, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Thursday, November 09, 2023
Cue Biopharma Q3 EPS $(0.24) Beats $(0.34) Es...
Benzinga Newsdesk
Monday, November 06, 2023
Piper Sandler Maintains Overweight on Cue Bio...
Benzinga Newsdesk
Friday, November 03, 2023
Cue Biopharma Presents New Data From Phase 1 ...
Benzinga Newsdesk
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, October 02, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Tuesday, September 26, 2023
Cue Biopharma Has Completed Patient Enrollmen...
Benzinga Newsdesk
Wednesday, August 30, 2023
Cue Biopharma And 2 Other Stocks Under $3 Insiders Are Buying
Lisa Levin
Wednesday, August 09, 2023
Cue Biopharma Q2 EPS $(0.29) Beats $(0.30) Es...
Benzinga Newsdesk
Earnings Scheduled For August 9, 2023
Benzinga Insights
Wednesday, July 26, 2023
Cue Biopharma SVP Awarded $284K Worth of Stock Options
Benzinga Insights
Chief Executive Officer at Cue Biopharma Acquires Company Stock Options Worth 450,000 Shares
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
